241 related articles for article (PubMed ID: 9262938)
1. Clomipramine augmentation in treatment-resistant depression.
Amsterdam JD; García-España F; Rosenzweig M
Depress Anxiety; 1997; 5(2):84-90. PubMed ID: 9262938
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Gómez Gómez JM; Teixidó Perramón C
J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Roth M; Guelfi JD
Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants.
Souêtre E; Martin P; Lozet H; Monteban H
Int Clin Psychopharmacol; 1996 Mar; 11(1):45-52. PubMed ID: 8732313
[TBL] [Abstract][Full Text] [Related]
5. [Tolerability and efficacy of combined antidepressant therapy].
Gándara Martín Jde L; Agüera Ortiz L; Ferre Navarrete F; Rojo Rodés E; Ros Montalbán S;
Actas Esp Psiquiatr; 2002; 30(2):75-84. PubMed ID: 12028939
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
7. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Strobel M; Warnke A; Roth M; Schulze U
Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
[TBL] [Abstract][Full Text] [Related]
8. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
Lader M
J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):20-4. PubMed ID: 6355073
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
Szegedi A; Wetzel H; Leal M; Härtter S; Hiemke C
J Clin Psychiatry; 1996 Jun; 57(6):257-64. PubMed ID: 8666564
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
Tundo A; de Filippis R; Proietti L
World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
Braconnier A; Le Coent R; Cohen D;
J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):22-9. PubMed ID: 12500073
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
13. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
16. [Combining antidepressants: a useful strategy for therapy resistant depression?].
Schmauss M; Messer T
Fortschr Neurol Psychiatr; 2009 Jun; 77(6):316-25. PubMed ID: 19415584
[TBL] [Abstract][Full Text] [Related]
17. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
Ottevanger EA
Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
[TBL] [Abstract][Full Text] [Related]
19. SSRI-TCA combination in the treatment of resistant depression.
Terao T; Ikemura N
J Clin Psychiatry; 2000 Jul; 61(7):529. PubMed ID: 10937615
[No Abstract] [Full Text] [Related]
20. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
Bech P; Stage KB; Larsen JK; Vestergaard P; Gram LF;
J Affect Disord; 2012 Nov; 140(3):253-9. PubMed ID: 22381949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
